Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,619,000 | 1,380,000 | 934,811 | 624,963 | 2,135,952 |
| Marketable Securities | 1,607,000 | 1,574,000 | 1,617,862 | 1,645,309 | 2,171,479 |
| Receivables | 799,000 | 937,000 | 930,094 | 890,042 | 681,262 |
| Inventories | 12,000 | 9,000 | 10,465 | 5,195 | 15,434 |
| Other current assets | 0 | 0 | 1 | -1 | -1 |
| TOTAL | $4,037,000 | $3,900,000 | $3,493,233 | $3,165,509 | $5,004,126 |
| Non-Current Assets | |||||
| PPE Net | 145,000 | 137,000 | 134,281 | 137,374 | 136,427 |
| Investments And Advances | 30,000 | 32,000 | 27,859 | 28,283 | 22,277 |
| Intangibles | 2,111,000 | 2,083,000 | 2,050,482 | 2,096,534 | 3,349 |
| Other Non-Current Assets | 263,000 | 262,000 | 140,029 | 145,022 | 174,429 |
| TOTAL | $2,549,000 | $2,514,000 | $2,352,651 | $2,407,213 | $336,482 |
| Total Assets | $6,586,000 | $6,414,000 | $5,845,884 | $5,572,722 | $5,340,608 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 507,000 | 489,000 | 469,027 | 490,620 | 365,747 |
| Other current liabilities | 6,000 | 3,000 | N/A | N/A | N/A |
| TOTAL | $756,000 | $744,000 | $675,829 | $629,725 | $401,710 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 5,749 | 4,762 | 4,805 |
| Other Non-Current Liabilities | 204,000 | 203,000 | 136,345 | 137,518 | 137,446 |
| TOTAL | $534,000 | $533,000 | $464,752 | $474,170 | $207,334 |
| Total Liabilities | $1,290,000 | $1,277,000 | $1,140,581 | $1,103,895 | $609,045 |
| Shareholders' Equity | |||||
| Common Shares | 10,000 | 10,000 | 9,728 | 9,524 | 9,610 |
| Retained earnings | 3,537,000 | 3,392,000 | 2,892,430 | 2,616,592 | 2,883,317 |
| Other shareholders' equity | -213,000 | -226,000 | -51,000 | 33,766 | 15,724 |
| TOTAL | $5,296,000 | $5,137,000 | $4,705,303 | $4,468,827 | $4,731,563 |
| Total Liabilities And Equity | $6,586,000 | $6,414,000 | $5,845,884 | $5,572,722 | $5,340,608 |